Clinical Trial Update: Use of Mesenchymal Stem Cells (MSCs) Differentiated Into Neural Stem Cells (NSCs) in People With Parkinson's (PD). [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating mesenchymal stem cells differentiated into neural stem cells for Parkinson's disease across Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Mesenchymal stem cells differentiated into neural stem cells

Snippet

Sponsor: University of Jordan | Conditions: Parkinson Disease | Phase 1, Phase 2 | Status: UNKNOWN